Day 2 (22 Aug 2024)

DAY 2 – 22 AUGUST 2024 (THURSDAY)

8.30am - 9.00am (SGT)

Registration

Session 4

9.00am - 9.30am (SGT)

Plenary Talk 3

Grand Ballroom

Implementing genomic medicine into clinical practice – a national and international perspective

Prof Kathryn North

Murdoch Children's Research Institute

9.30am - 10.55am (SGT)

Biobanks for Precision Medicine

This session aims to explore the pivotal role of biobanks in Asia, Europe and the USA and how they are facilitating the seamless transition from cohort studies to clinical application.

Grand Ballroom

FinnGen, an example of a Northern European large scale biobank study

Prof Aarno Palotie

Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Finland and Broad institute and Massachusetts General Hospital, Boston, USA

The All of Us Research Program

Dr Geoffrey Ginsburg

All of Us Research Program, National Institutes of Health

Challenge for Personalized Healthcare: the Tohoku Medical Megabank Project

Prof Masayuki Yamamoto

Tohoku University Tohoku Medical Megabank Organization (ToMMo)

Moderator

Prof Nahla Afifi

International Health Cohorts Consortium (IHCC)

10.55am - 11.15am (SGT)

Teabreak Networking Session

Session 5

11.15am - 12.40pm (SGT)

Pharmacogenomics

This session aims to explore the relationship between an individual’s genotype and their response to medicines. Specific population data and regional implementation practices that have the potential for making better medication and dosing decisions will be presented.

Grand Ballroom

Rethinking Pharmacogenomics - Implementing Pre-emptive Pharmacogenomics in a Singapore Healthcare System

Dr Elaine Lo Ah Gi

National University Hospital

Pharmacogenomics implementation: towards precision medicine

Prof Collet Dandara

University of Cape Town

Clinical pharmacogenomics implementation in Thailand: a dream come true

Prof Chonlaphat Sukasem

Ramathibodi Hospital, Mahidol University

Moderator

Mr Grant M. Wood

Global Genomic Medicine Collaborative (GGMC)

12.40pm - 2.00pm (SGT)

Parallel Track 1: Lunch Time Industry Talk

Grand Ballroom

Presentation by Illumina

Deep learning for precision medicine and drug target discovery

Dr Kyle Farh

Illumina

Parallel Track 2: Lunch Time Industry Talk

Meeting Room

Presentation by Olink

Towards precision prevention: plasma proteomics for screening and risk prediction.

Dr Julia Carrasco-Zanini Sanchez

Queen Mary University of London

Presentation by Oxford Nanopore Technologies

The Era of Complete Genomes

Ms Cora Vacher

Oxford Nanopore Technologies

Parallel Track 3: Oral Presentations (Early Career Investigators)

Wisteria & Camellia Villa

Presenter 1:

A proposed framework prioritizing pharmacogenomic drug-gene interactions in an Asian context for chemotherapy

Dr Janice Goh

Bioinformatics Institute, Agency for Science, Technology and Research

Presenter 2:

Empiric treatment with aspirin and ticagrelor is the most cost-effective strategy in patients with minor stroke or transient ischemic attack

Dr Kaavya Narasimhalu

National Neuroscience Institute

Presenter 3:

Statin Lactone Metabolism is a Determinant of 5-year Cardiovascular Outcomes Independent of Serum Cholesterol

Eugene Goh

National University of Singapore

Presenter 4:

Cost-effectiveness of Pre-emptive Pharmacogenetic Panel Testing versus No Testing in a Multi-ethnic Asian Population

Jamaica Roanne Briones

National University of Singapore

Presenter 5:

Unlocking Medical Insights through the Power of Taiwan Biobank Whole Genome Data

Dr Jacob Hsu Shujui

National Taiwan University

Session 6

2.00pm - 3.20pm (SGT)

Parallel Track 1: Biobanks for Precision Medicine

This session aims to explore the pivotal role of biobanks in Asia, Europe and the USA and how they are facilitating the seamless transition from cohort studies to clinical application.

Grand Ballroom

Functional Genomic Studies in Asia: Design and Exemplar Results from the PRECISE-SG100K Program

Prof John Chambers

Precision Health Research, Singapore

Harnessing the power of proteomics in biobanks to advance precision health

Prof Chen Zhengming

University of Oxford

Genetic analysis of quantitative traits in the Taiwan Biobank

Dr Lin Yen-Feng

National Health Research Institutes, Taiwan

Moderator

Dr Geoffrey Ginsburg

All of Us Research Program, National Institutes of Health

Parallel Track 2: Rare Diseases

Rare diseases pose unique challenges and collaboration is essential in addressing the complexities of rare diseases and to drive innovation in research and patient care. This session aims to facilitate dialogue between researchers and clinicians invested in advancing rare disease research.

Meeting Room

Singapore Undiagnosed Research Endeavour

Dr Saumya Jamuar

KK Women's and Children's Hospital

Genomics of Rare Diseases for Health Equity in Mexico and Latin America

Dr Claudia Gonzaga-Jauregui

International Laboratory for Human Genome Research, UNAM

Implementing a Rare Diseases Program in Chile. What have we learned?

Dr Gabriela Repetto

Universidad del Desarrollo

Moderator

Prof Duangrurdee Wattanasirichaigoon

Faculty of Medicine Ramathibodi Hospital, Mahidol University

Parallel Track 3: Fireside Chat

Wisteria & Camellia Villa

Dr Mark McCarthy

Genentech

Prof Martin Delatycki

Murdoch Children's Research Institute

Prof Nicki Tiffin

South African National Bioinformatics Institute, University of the Western Cape

Moderator

Prof Sarah Bauermeister

University of Oxford

3.20pm - 4.00pm (SGT)

Teabreak Networking Session

Session 7

4.00pm - 5.20pm (SGT)

Parallel Track 1: Genomic/Precision Medicine for Therapeutic R&D

This session aims to explore the application of genomic analyses to discover, validate and develop novel therapeutic targets, biomarkers and genes that affect the efficacy and safety of new medicines.

Grand Ballroom

The Together for CHANGE™ Initiative: A Public-Private Partnership Expanding Genomics Research

Dr Lyndon Mitnaul

Regeneron Genetics Center

Transforming Drug Discovery with large-scale genomics

Dr Guillermo Del Angel

AstraZeneca

Embedding multimodal discovery in pharma R&D

Dr Mark McCarthy

Genentech

Moderator

Dr Scott Sundseth

International Health Cohorts Consortium (IHCC)

Parallel Track 2: Training/Early Career Scientists

This session is open to all Early Career Scientists and will delve into the essential components of nurturing and supporting emerging scientists as they navigate through multifaceted ecosystems that make up their academic and professional pathways.

Meeting Room

Nurturing the physician-scientists needed to make precision medicine a reality

Dr Sharon Plon

Baylor College of Medicine

Nanocourse: Providing Genomics Researchers with Clinical Perspective

Prof Richard Haspel

Beth Israel Deaconess Medical Center and Harvard Medical School

Inclusion, Equity, and Capacity Building for Early Career Genomics Research Fellows

Dr Victoria Nembaware

University of Cape Town

Moderator

Prof Michele Ramsay

University of the Witwatersrand

4.00pm - 5.00pm (SGT)

Parallel Track 3: Industry Talk

Wisteria & Camellia Villa

Panel Discussion by NalaGenetics

Panelists: Dr Goh Liuh Ling, Dr Elaine Lo, Representative from BB Binomika, Ministry of Health Indonesia

Moderator: Dr Mar Gonzalez-porta, NalaGenetics Pte Ltd

*Programme is accurate as of 15 August 2024.